切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2020, Vol. 09 ›› Issue (05) : 507 -511. doi: 10.3877/cma.j.issn.2095-3224.2020.05.013

所属专题: 文献

综述

右半结肠癌淋巴结清扫范围的临床研究进展
刘赛靓1, 周勇2, 俞旻皓1, 钟鸣1,()   
  1. 1. 200127 上海交通大学医学院附属仁济医院胃肠外科
    2. 201800 上海嘉定中医医院外科
  • 收稿日期:2020-04-01 出版日期:2020-10-25
  • 通信作者: 钟鸣
  • 基金资助:
    国家自然科学基金(No.81702300,No.81873555)

The extent of lymph node excision in right hemicolectomy: a clinical review of the progression in lymphadenectomy

Sailiang Liu1, Yong Zhou2, Minhao Yu1, Ming Zhong1,()   

  1. 1. Department of Colorectal Surgery, Renji Hospital, School of Medicine, Jiaotong University, Shanghai 200127, China
    2. Department of Surgery, Jiading Hospital of Traditional Chinese Medicine, Shanghai 201800, China
  • Received:2020-04-01 Published:2020-10-25
  • Corresponding author: Ming Zhong
  • About author:
    Corresponding author: Zhong Ming, Email:
引用本文:

刘赛靓, 周勇, 俞旻皓, 钟鸣. 右半结肠癌淋巴结清扫范围的临床研究进展[J]. 中华结直肠疾病电子杂志, 2020, 09(05): 507-511.

Sailiang Liu, Yong Zhou, Minhao Yu, Ming Zhong. The extent of lymph node excision in right hemicolectomy: a clinical review of the progression in lymphadenectomy[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2020, 09(05): 507-511.

结直肠癌是一种常见的消化道恶性肿瘤,其中,右半结肠切除联合区域淋巴结清扫是右半结肠癌的标准术式。然而目前对右半结肠癌的淋巴结清扫范围尚未达成统一,欧美指南推荐的全结肠系膜切除(CME)合并中央血管结扎术(CVL),并未对淋巴结清扫范围有明确界定,而日本指南提出的D3手术风险较大,似乎有过度治疗之嫌。国内右半结肠癌手术推崇欧美的CME原则,而淋巴结清扫却效仿日本D2/D3的手术范围,至今尚未形成统一规范。本文将就右半结肠癌淋巴转移特点,和D2/D3淋巴结清扫的利弊做一综述。

Colorectal cancer is one of the most common malignant digestive tumors, of which colectomy combined with regional lymphadenectomy is the standard treatment. However, the extent of lymphadenectomy has not reached a consensus. The concept of complete mesocolic excision (CME) with central vascular ligation (CVL) proposed by European surgeons has not made a clear definition about the margin of lymph node excision, while D3 lymphadenectomy proposed by Japanese guideline proved to have more perioperative risks, which seems some kind of over-treatment. In our country, right hemicolectomy standard has not been established, surgeons perform right colectomy following the CME strategy and lymphadenectomy following D2/D3 excision standard. So, we reviewed the characteristics of lymph node metastasis of right colon cancer, and the advantages and disadvantages of D2/D3 lymphadenectomy.

图1 右半结肠癌淋巴结转移示意图[13]
图2 右半结肠癌D1、D2、D3手术范围示意图[14]。SMV:肠系膜上静脉,SMA:肠系膜上动脉
[1]
陈万青,孙可欣,郑荣寿,等. 2014年中国分地区恶性肿瘤发病和死亡分析[J].中国肿瘤, 2018, 27(1): 1-14.
[2]
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO) 结直肠癌诊疗指南(2019) [M]. 北京: 人民卫生出版社, 2019.
[3]
童宜欣,龚建平. 右半结肠癌D3+CME关键技术[J/CD]. 中华结直肠疾病电子杂志, 2017, 6(4): 280-283.
[4]
Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer [J]. Int J Clin Oncol, 2020, 25(1): 1-42.
[5]
Park IJ, Choi GS, Kang BM, et al. Lymph node metastasis patterns in right-sided colon cancers: is segmental resection of these tumors oncologically safe? [J]. Ann Surg Oncol, 2009, 16(6): 1501-1506.
[6]
Klein CA. Parallel progression of primary tumours and metastases [J]. Nature Reviews Cancer, 2009, 9(4): 302-312.
[7]
Liang JT, Lai HS, Huang J, et al. Long-term oncologic results of laparoscopic D3 lymphadenectomy with complete mesocolic excision for right-sided colon cancer with clinically positive lymph nodes [J]. Surg Endosc, 2015, 29(8): 2394-2401.
[8]
Liang JT, Huang KC, Lai HS, et al. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes [J]. Ann Surg Oncol, 2007, 14(7): 1980-1990.
[9]
Fisher B. Biological research in the evolution of cancer surgery: a personal perspective [J]. Cancer Research, 2008, 68(24): 10007-10020.
[10]
Kataoka K, Ysebaert H, Shiozawa M, et al. Prognostic significance of number versus location of positive mesenteric nodes in stage iii colon cancer [J]. Eur J Surg Oncol, 2019, 45(10): 1862-1869.
[11]
Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089 [J]. J Clin Oncol, 2003, 21(15): 2912-2919.
[12]
Chen S. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study [J]. Annals of Surgery, 2006, 244(4): 602.
[13]
Kim NK, Sugihara K, Liang JT. Surgical treatment of colorectal cancer [M]. Berlin: Springer, 2018.
[14]
Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer [J]. Int J Clin Oncol, 2012, 17(1): 1-29.
[15]
Faerden AE, Sjo OH, Bukholm IRK, et al. Lymph node micrometastases and isolated tumor cells influence survival in stage Ⅰ and Ⅱ colon cancer [J]. Diseases of the Colon & Rectum, 2011, 54(2): 200-206.
[16]
Parnaby CN, Scott NW, Ramsay G, et al. Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection [J]. British Journal of Cancer, 2015, 113(2): 212-219.
[17]
Johnson PM, Porter GA, Ricciardi R, et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer [J]. J Clin Oncol, 2006, 24(22): 3570-3575.
[18]
Hohenberger W, Weber K, Matzel K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome [J]. Colorectal Dis, 2009, 11(4): 354-365.
[19]
Kanemitsu Y, Komori K, Kimura K, et al. D3 lymph node dissection in right hemicolectomy with a no-touch isolation technique in patients with colon cancer [J]. Diseases of the Colon & Rectum, 2013, 56(7): 815-824.
[20]
Alhassan N, Yang M, Wong-Chong N, et al. Comparison between conventional colectomy and complete mesocolic excision for colon cancer: a systematic review and pooled analysis : A review of CME versus conventional colectomies [J]. Surg Endosc, 2019, 33(1): 8-18.
[21]
Bertelsen CA, Neuenschwander AU, Jansen JE, et al. Short-term outcomes after complete mesocolic excision compared with 'conventional' colonic cancer surgery [J]. British Journal of Surgery, 2016, 103(5): 581-589.
[22]
Han DP, Lu AG, Hao F. Long-term results of laparoscopy-assisted radical right hemicolectomy with D3 lymphadenectomy: clinical analysis with 177 cases [J]. International Journal of Colorectal Disease, 2013, 28(5): 623-629.
[23]
Numata M, Sawazaki S, Aoyama T, et al. D3 lymph node dissection reduces recurrence after primary resection for elderly patients with colon cancer [J]. Int J Colorectal Dis, 2019, 34(4): 621-628.
[24]
Thorsen Y, Stimec B, Andersen SN, et al. Bowel function and quality of life after superior mesenteric nerve plexus transection in right colectomy with D3 extended mesenterectomy [J]. Techniques in Coloproctology, 2016, 20(7): 445-453.
[25]
Olofsson F, Buchwald P, Elmståhl S, et al. No benefit of extended mesenteric resection with central vascular ligation in right-sided colon cancer [J]. Colorectal Dis, 2016, 18(8): 773-778.
[26]
Shin JW, Amar AHY, Kim SH, et al. Complete mesocolic excision with D3 lymph node dissection in laparoscopic colectomy for stages II and III colon cancer: long-term oncologic outcomes in 168 patients [J]. Techniques in Coloproctology, 2014, 18(9): 795-803.
[27]
Kotake K, Mizuguchi T, Moritani K, et al. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer [J]. Int J Colorectal Dis, 2014, 29(7): 847-852.
[28]
Storli KE, Søndenaa K, Furnes B, et al. Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-II [J]. Tech Coloproctol, 2014, 18(6): 557-564.
[29]
Storli KE, Søndenaa K, Bukholm IR, et al. Overall survival after resection for colon cancer in a national cohort study was adversely affected by TNM stage, lymph node ratio, gender, and old age [J]. Int J Colorectal Dis, 2011, 26(10): 1299-1307.
[30]
Killeen S, Mannion M, Devaney A, et al. Complete mesocolic resection and extended lymphadenectomy for colon cancer: a systematic review [J]. Colorectal Disease, 2014, 16(8): 577-594.
[31]
Mathis KL, Green EM, Sargent DJ, et al. Surgical quality surrogates do not predict colon cancer survival in the setting of technical credentialing a report from the prospective cost trial [J]. Annals of surgery, 2012, 257(1): 102-107.
[32]
肖毅,徐徕,陆君阳. 腹腔镜右半结肠癌切除淋巴结清扫范围及意义[J/CD].中华普外科手术学杂志(电子版), 2018, 12(3): 185-188.
[33]
Bertelsen CA, Neuenschwander AU, Jansen JE, et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study [J]. The Lancet Oncology, 2015, 16(2): 161-168.
[34]
Galizia G, Lieto E, Vita F, et al. Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers? A prospective study [J]. International Journal of Colorectal Disease, 2014, 29(1): 89-97.
[35]
Hida JI, Okuno K, Yasutomi M, et al. Optimal ligation level of the primary feeding artery and bowel resection margin in colon cancer surgery: the influence of the site of the primary feeding artery [J]. Diseases of the Colon & Rectum, 2005, 48(12): 2232-2237.
[36]
Coller FA, Kay EB, Macintyre RS. Regional lymphatic metastases of carcinoma of the colon [J]. Ann Surg, 1941, 114(1): 56-67.
[37]
Vladimir B, Mihail M. Comparison of D2 vs. D3 lymph node dissection for right colon cancer (RICON). [EB/OL] [2020-04-01].

URL    
[38]
Lu JY, Xu L, Xue HD, et al. The radical extent of lymphadenectomy-D2 dissection versus complete mesocolic excision of laparoscopic Right colectomy for right-sided colon cancer (RELARC) trial: study protocol for a randomized controlled trial [J]. Trials, 2016, 17(1): 582.
[39]
Karachun A, Petrov A, Panaiotti L, et al. Protocol for a multicentre randomized clinical trial comparing oncological outcomes of D2 versus D3 lymph node dissection in colonic cancer (COLD trial) [J]. BJS Open, 2019, 3(3): 288-298.
[1] 李志伟, 向琪, 彭胜男, 郭玲, 孙贱根, 杨川. 右美托咪定与曲马多分别复合罗哌卡因在全麻下结肠癌根治术中的应用[J]. 中华普通外科学文献(电子版), 2023, 17(03): 182-185.
[2] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[3] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[4] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[5] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[6] 徐伯麒, 陶亮, 章帆, 毛忠琦. 结肠癌患者淋巴结转移预测模型的建立[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 393-397.
[7] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[8] 侯文运, 刘恒昌, 窦利州, 陈海鹏, 郑朝旭, 王贵齐, 王锡山. 腹部无辅助切口内镜引导下取标本的腹腔镜辅助右半结肠癌根治术(保留回盲部)(附视频)[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 436-440.
[9] 唐新, 刁德昌, 廖伟林, 林佳鑫, 汪佳豪, 李文娟, 谢嘉欣, 敖琳, 李洪明, 易小江, 卢新泉, 冯晓创. 保留神经的鞘外游离技术在腹腔镜右半结肠癌D3根治术中的近远期疗效分析:基于倾向性评分匹配的回顾性队列研究[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 372-380.
[10] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[11] 常远, 白杨, 王文秀, 孙振强, 周全博, 崔雯铭, 王玉行, 袁维堂, 胡军红. 电子结肠镜辅助经结肠取标本手术在结肠肿瘤中的临床应用分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 196-199.
[12] 邓振汝, 林树文, 吕泽坚, 郑佳彬, 廖乾超, 冯伙伦, 吴德庆, 王俊江, 李勇. 横结肠切除与扩大结肠切除治疗横结肠癌疗效比较[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 214-220.
[13] 路继永, 王帅, 张成仁, 吴德望, 杨熊飞. 腹腔镜右半结肠切除应用现状[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 221-227.
[14] 李峻峰, 李军, 孙勤丰, 孙建光, 孔祥兴. 九例结肠髓样癌的临床病理特征分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 248-252.
[15] 徐正, 苏昊, 包满都拉, 罗寿, 张岳阳, 关旭, 张明光, 赵志勋, 梁建伟, 刘正, 刘骞, 王锡山, 周海涛. 经末段回肠系膜后隧道完成重叠式三角吻合的结肠脾曲癌完全腹腔镜左半结肠切除术23例临床分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 253-259.
阅读次数
全文


摘要